[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @doepke_michel Michel Doepke Michel Doepke posts on X about $sny, $crnx, $ptgx, market cap the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours. ### Engagements: XXXXX [#](/creator/twitter::1350720698591936515/interactions)  - X Week XXXXXX -XX% - X Month XXXXXXX -XX% - X Months XXXXXXXXX +73% - X Year XXXXXXXXX +146% ### Mentions: XX [#](/creator/twitter::1350720698591936515/posts_active)  - X Week XXX -XX% - X Month XXX -XX% - X Months XXXXX +46% - X Year XXXXX +153% ### Followers: XXXXX [#](/creator/twitter::1350720698591936515/followers)  - X Week XXXXX +0.82% - X Month XXXXX +3.30% - X Months XXXXX +26% - X Year XXXXX +51% ### CreatorRank: XXXXXXX [#](/creator/twitter::1350720698591936515/influencer_rank)  ### Social Influence **Social category influence** [stocks](/list/stocks) XXXXX% [cryptocurrencies](/list/cryptocurrencies) XXXX% [finance](/list/finance) XXXX% [countries](/list/countries) XXXX% [travel destinations](/list/travel-destinations) XXXX% **Social topic influence** [$sny](/topic/$sny) #2, [$crnx](/topic/$crnx) #4, [$ptgx](/topic/$ptgx) #7, [market cap](/topic/market-cap) #235, [$bpmc](/topic/$bpmc) #1, [$idya](/topic/$idya) #4, [$jnj](/topic/$jnj) #21, [$11b](/topic/$11b) #10, [$abvx](/topic/$abvx) #11, [$cldx](/topic/$cldx) #1 **Top accounts mentioned or mentioned by** [@aggregategains](/creator/undefined) [@biohazard3737](/creator/undefined) [@bionavgator](/creator/undefined) [@midwit_capital](/creator/undefined) [@wallstsai](/creator/undefined) [@semodough](/creator/undefined) [@amaymd](/creator/undefined) [@damiangarde](/creator/undefined) [@persimmonti](/creator/undefined) [@protagonisttxs](/creator/undefined) [@seekingalpha](/creator/undefined) [@aktionaer](/creator/undefined) [@reddit](/creator/undefined) [@meadowcapital](/creator/undefined) [@maximizebelief2](/creator/undefined) [@sanityninsanity](/creator/undefined) [@mugsley](/creator/undefined) [@biotech2k1](/creator/undefined) [@andybradley93](/creator/undefined) [@phoenicianstrat](/creator/undefined) **Top assets mentioned** [Synthetify (SNY)](/topic/$sny) [Crinetics Pharmaceuticals, Inc. (CRNX)](/topic/$crnx) [Protagonist Therapeutics, Inc (PTGX)](/topic/$ptgx) [Blueprint Medicines Corporation (BPMC)](/topic/$bpmc) [IDEAYA Biosciences, Inc. Common Stock (IDYA)](/topic/$idya) [Johnson & Johnson (JNJ)](/topic/$jnj) [Celldex Therapeutics, Inc (CLDX)](/topic/$cldx) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) [Novartis AG (NVS)](/topic/$nvs) [Pfizer, Inc. (PFE)](/topic/$pfe) [Kymera Therapeutics, Inc. Common Stock (KYMR)](/topic/$kymr) [Cogent Biosciences, Inc. Common Stock (COGT)](/topic/$cogt) [Insmed, Inc. (INSM)](/topic/$insm) [Vertex Protocol (VRTX)](/topic/$vrtx) [GRAIL, Inc. Common Stock (GRAL)](/topic/$gral) [Metsera, Inc. Common Stock (MTSR)](/topic/$mtsr) [Ionis Pharmaceuticals, Inc. Common Stock (IONS)](/topic/$ions) [Intra-Cellular Therapies Inc. (ITCI)](/topic/$itci) [Revolution Medicines, Inc. Common Stock (RVMD)](/topic/$rvmd) [Travere Therapeutics, Inc. Common Stock (TVTX)](/topic/$tvtx) [Eli Lilly and Company (LLY)](/topic/$lly) [Exact Sciences Corp (EXAS)](/topic/$exas) [Illumina, Inc. (ILMN)](/topic/$ilmn) [GSK plc (GSK)](/topic/$gsk) [United Community Banks, Inc. (UCB)](/topic/$ucb) [Dawn Protocol (DAWN)](/topic/$dawn) [One Cash (ONC)](/topic/$onc) [Jazz Pharmaceuticals, Inc. (JAZZ)](/topic/$jazz) [Seagen Inc (SGEN)](/topic/$sgen) [Array Technologies, Inc. Common Stock (ARRY)](/topic/$arry) [Biohaven Pharmaceutical Holding Company Ltd. (BHVN)](/topic/$bhvn) [Biogen Inc (BIIB)](/topic/$biib) [Scholar Rock Holding Corporation Common Stock (SRRK)](/topic/$srrk) [MON Protocol (MON)](/topic/$mon) [uniQure N.V. (QURE)](/topic/$qure) [AbbVie Inc (ABBV)](/topic/$abbv) [Halozyme Therapeutics, Inc. (HALO)](/topic/$halo) [Merck & Co., Inc. (MRK)](/topic/$mrk) [Praxis Precision Medicines, Inc. Common Stock (PRAX)](/topic/$prax) [Natera, Inc. Common Stock (NTRA)](/topic/$ntra) [Agios Pharmaceuticals, Inc. (AGIO)](/topic/$agio) [CRISPR Therapeutics AG (CRSP)](/topic/$crsp) [Lantheus Holdings, Inc (LNTH)](/topic/$lnth) [Summit Therapeutics Inc. Common Stock (SMMT)](/topic/$smmt) [Cytokinetics Inc. (CYTK)](/topic/$cytk) [Edgewise Therapeutics, Inc. Common Stock (EWTX)](/topic/$ewtx) ### Top Social Posts Top posts by engagements in the last XX hours "$REGN $SNY Dupixent (dupilumab) Approved as the First Targeted Medicine in the European Union (EU) in Over a Decade for Chronic Spontaneous Urticaria (CSU). $CLDX" [X Link](https://x.com/doepke_michel/status/1993209633776058880) 2025-11-25T06:46Z 5922 followers, 12.2K engagements "$SNY $BPMC At first glance Ayvakit's weak sales figures are misleading. "Consolidated from July XX 2025. On a pro-forma basis Q3 2025 sales were $204m an increase of XX% from $128m in Q3 2024."" [X Link](https://x.com/doepke_michel/status/1981619072690208884) 2025-10-24T07:09Z 5922 followers, 7260 engagements "#Otsuka Receives FDA Accelerated Approval for VOYXACT (sibeprenlimab-szsi) for the Reduction of Proteinuria in Adults with Primary Immunoglobulin A Nephropathy (IgAN) at Risk for Disease Progression. $VRTX $NVS $TVTX" [X Link](https://x.com/doepke_michel/status/1993651846406340989) 2025-11-26T12:03Z 5922 followers, 1404 engagements "Exclusive: I met Jennifer Ruddock CBO of $NKTR at BIO Europe in Vienna. Read the interview (Part 1) 👇 $LLY" [X Link](https://x.com/doepke_michel/status/1995059367524315634) 2025-11-30T09:16Z 5922 followers, 9267 engagements "$CLDX strength up X% after $JSPR asthma data" [X Link](https://x.com/doepke_michel/status/1995903104068223261) 2025-12-02T17:09Z 5922 followers, 2174 engagements "$PCSC Freenome and Perceptive Capital Solutions Corp Announce Business Combination Agreement to Create a Publicly Listed Company Transforming Blood-Based Multi-Cancer Detection through an AI/ML-Enabled Multiomics Platform. $GRAL $ILMN $EXAS" [X Link](https://x.com/doepke_michel/status/1996940950199804286) 2025-12-05T13:53Z 5922 followers, 1908 engagements "$GSK GSK terminates collaboration agreement with $IDYA" [X Link](https://x.com/doepke_michel/status/1997198425603858615) 2025-12-06T06:56Z 5922 followers, 8346 engagements "$PTGX early stage program but PN-881 could have gamechanger potential. It's incredible how strongly $UCB is growing with Bimzelx. A multi-billion dollar opportunity - and $JNJ may be aware of this potential. Maybe we get a PR tomorrow - $JNJ to report Q3 results on Tuesday. $NVS" [X Link](https://x.com/doepke_michel/status/1977440495404982474) 2025-10-12T18:25Z 5920 followers, 7071 engagements "$DAWN to Acquire $MRSN - $XX per share + CVR" [X Link](https://x.com/doepke_michel/status/1988954785614295455) 2025-11-13T12:59Z 5920 followers, 1167 engagements "$ONC Positive Phase X Results Support ZIIHERA as HER2-Targeted Therapy-of-Choice and Combination with TEVIMBRA and Chemotherapy as New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma $JAZZ $ZYME" [X Link](https://x.com/doepke_michel/status/1990375217924100198) 2025-11-17T11:03Z 5918 followers, 3290 engagements "$SGEN ($43B) $ARNA ($7B) $GBT ($5B) $ARRY ($11B) $MTSR ($8B upfront) $TRIL ($2B) $MDVN ($14B) $BHVN ($12B) = $102B. $PFE market cap: $144B" [X Link](https://x.com/doepke_michel/status/1990803460783288528) 2025-11-18T15:25Z 5920 followers, 131.1K engagements "Like $PALI into 2026. The stock could get a boost if $ABVX is actually acquired. Interesting: Sharon Skare the new Vice President Global Head of Clinical Operations previously worked at Abivax. She knows how to run larger trials in IBD. Previous jobs at $PFE and $ARNA" [X Link](https://x.com/doepke_michel/status/1991861009188073783) 2025-11-21T13:27Z 5920 followers, 19.7K engagements "#Eisai Submits New Drug Application for Subcutaneous Formulation of Leqembi for the Treatment of Early Alzheimers Disease in Japan. $BIIB $BIOA.ST" [X Link](https://x.com/doepke_michel/status/1994302384391020941) 2025-11-28T07:08Z 5910 followers, 1846 engagements "$SRRK strength" [X Link](https://x.com/doepke_michel/status/1996250962726473808) 2025-12-03T16:11Z 5921 followers, 1080 engagements "Influential study on #glyphosate safety retracted XX years after publication - "several critical issues that are considered to undermine the academic integrity of this article and its conclusions." $MON $BAYN #Bayer #Glyphosat" [X Link](https://x.com/doepke_michel/status/1996486418747838611) 2025-12-04T07:47Z 5906 followers, XXX engagements "$QURE Provides Regulatory Update on AMT-130 for Huntingtons Disease" [X Link](https://x.com/doepke_michel/status/1996552702063706516) 2025-12-04T12:10Z 5921 followers, 3908 engagements "$PLRX Announces Interim Data from PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors" [X Link](https://x.com/doepke_michel/status/1996560128338714857) 2025-12-04T12:40Z 5910 followers, 1165 engagements "What else can $ABBV say Rinvoq and Skyrizi are THE growth drivers in the portfolio following the Humira patent cliff. Competition is not welcome here - I can imagine that AbbVie will purchase/license further assets in this area and in the field of obesity. $ABVX $GUBRA" [X Link](https://x.com/doepke_michel/status/1996592436798177628) 2025-12-04T14:48Z 5920 followers, 2821 engagements "$HALO Wins Preliminary Injunction Against Merck's Keytruda SC in Germany. $MRK" [X Link](https://x.com/doepke_michel/status/1996649123282583603) 2025-12-04T18:33Z 5920 followers, 2369 engagements "$PRAX Announces Positive Pre-NDA Meeting with FDA for Ulixacaltamide in Essential Tremor" [X Link](https://x.com/doepke_michel/status/1996687174943789298) 2025-12-04T21:04Z 5921 followers, 2041 engagements "$NTRA Acquires #Foresight Diagnostics - all-stock transaction consisting of a $XXX million upfront with an additional $XXX million in earnouts tied to the achievement of revenue- and reimbursement-based milestones" [X Link](https://x.com/doepke_michel/status/1996914590115156429) 2025-12-05T12:08Z 5921 followers, 1656 engagements "$AGIO Announces Topline Results from RISE UP Phase X Trial of Mitapivat in Sickle Cell Disease. $CRSP $VRTX" [X Link](https://x.com/doepke_michel/status/1991115109171863846) 2025-11-19T12:03Z 5921 followers, 3200 engagements "$KYMR Announces First Patient Dosed in BROADEN2 Phase 2b Atopic Dermatitis Clinical Trial of KT-621 a First-in-Class Oral STAT6 Degrader" [X Link](https://x.com/doepke_michel/status/1993290108670558220) 2025-11-25T12:06Z 5922 followers, 2975 engagements "$PTGX strength into the weekend. Deal close $JNJ $TAK" [X Link](https://x.com/doepke_michel/status/1997033377338466753) 2025-12-05T20:00Z 5922 followers, 2828 engagements "$TLX Reports US$206M Revenue FY 2025 Revenue Guidance raised. $LNTH" [X Link](https://x.com/doepke_michel/status/1977982019045843176) 2025-10-14T06:17Z 5923 followers, 1448 engagements "$SMMT Akeso's Ivonescimab Secures Fourth Breakthrough Therapy Designation in China for First-Line Treatment of Triple-Negative Breast Cancer" [X Link](https://x.com/doepke_michel/status/1985230900939120854) 2025-11-03T06:21Z 5922 followers, 1970 engagements "$VTYX Provides Clinical and Corporate Updates" [X Link](https://x.com/doepke_michel/status/1995826196383191048) 2025-12-02T12:03Z 5921 followers, 1510 engagements "$IONS receives U.S. FDA Breakthrough Therapy designation for zilganersen for Alexander disease (AxD)" [X Link](https://x.com/doepke_michel/status/1995826765915205793) 2025-12-02T12:05Z 5921 followers, 1030 engagements "nHCM landscape (source: Barclays). $CYTK $LXRX $EWTX $TNYA $LXEO" [X Link](https://x.com/doepke_michel/status/1976610050870493287) 2025-10-10T11:25Z 5922 followers, 3309 engagements "$IDYA 52-week high" [X Link](https://x.com/doepke_michel/status/1983167716266762630) 2025-10-28T13:43Z 5922 followers, 4455 engagements "$IDYA despite 52-week high just $2.9B market cap. $992M cash at the end of June + $210M upfront payment from Servier. Financed over several years. Multiple shots on goal - I wouldn't be surprised if $IDYA trades above $XXX in the long term" [X Link](https://x.com/doepke_michel/status/1983480382101282839) 2025-10-29T10:25Z 5922 followers, 2459 engagements "$CRNX Q3 results next Thursday. I like the pipeline potential" [X Link](https://x.com/doepke_michel/status/1984613636711583755) 2025-11-01T13:28Z 5922 followers, 2406 engagements "$KRYS halted - Buyout" [X Link](https://x.com/doepke_michel/status/1985315082004320624) 2025-11-03T11:56Z 5922 followers, 9363 engagements "$CRNX pipeline. $1.1B Cash Balance Funds Current Operating Plan into 2029. Market cap: $4B. The focus is now on the commercial roll-out of Palsonify. $CAMX" [X Link](https://x.com/doepke_michel/status/1986739556469662007) 2025-11-07T10:16Z 5922 followers, 8977 engagements "$COGT Reports Positive Results from Bezuclastinib PEAK Phase X Trial in Gastrointestinal Stromal Tumors (GIST). $BPMC $SNY $DCPH" [X Link](https://x.com/doepke_michel/status/1987853240554381654) 2025-11-10T12:01Z 5921 followers, 17.3K engagements "$JNJ $ITCI Caplyta estimates: 2025e: $756M 2026e: $1.30B 2027e: $1.75B 2028e: $2.21B Icotrokinra: 2026e: $109M 2027e: $366M 2028e: $974M. Sales could be higher if $JNJ acquires $PTGX" [X Link](https://x.com/doepke_michel/status/1988199332219416636) 2025-11-11T10:57Z 5921 followers, 1197 engagements "$RLMD should receive more attention here. Small position. $ENGN $CGON" [X Link](https://x.com/doepke_michel/status/1988259990444904910) 2025-11-11T14:58Z 5921 followers, 7666 engagements "$AXSM new ATH - interesting potential buyout target. $BPMC $ITCI $VRNA and $SWTX gone (see list below)" [X Link](https://x.com/doepke_michel/status/1988631039414043064) 2025-11-12T15:32Z 5921 followers, 3884 engagements "Next bidding war M&A in the biotech space is heating up $AVDL Board of Directors Determines Proposal From #Lundbeck Reasonably Expected to Result in a Company Superior Proposal. $ALKS" [X Link](https://x.com/doepke_michel/status/1989285642531201519) 2025-11-14T10:53Z 5921 followers, 8217 engagements "$IONS DAWNZERA (donidalorsen) receives positive opinion from CHMP recommended for approval in EU for hereditary angioedema (HAE)" [X Link](https://x.com/doepke_michel/status/1989302948023640119) 2025-11-14T12:02Z 5921 followers, XXX engagements "$CRNX looking good" [X Link](https://x.com/doepke_michel/status/1990465859089736175) 2025-11-17T17:03Z 5921 followers, 1315 engagements "$INSM European Commission Approves BRINSUPRI (brensocatib) as the First and Only Treatment Approved for Non-Cystic Fibrosis Bronchiectasis in the European Union" [X Link](https://x.com/doepke_michel/status/1991033798914429427) 2025-11-19T06:40Z 5921 followers, 1838 engagements "$RNA Announces U.S. Managed Access Program (MAP) for Investigational Therapy del-zota in DMD44. $NVS $SRPT" [X Link](https://x.com/doepke_michel/status/1991149012368380290) 2025-11-19T14:18Z 5921 followers, 2651 engagements "What would $PTGX be worth if Icotrokinra and Rusfertide weren't partnered In my opinion $PTGX could be in the range of $INSM in terms of market cap in some years. Large markets ingenious technology (oral). What pharma wants - easily available" [X Link](https://x.com/doepke_michel/status/1991507308107493461) 2025-11-20T14:01Z 5922 followers, 8452 engagements "$CRNX Announces First Patient Randomized in Pivotal Phase X CAREFNDR Trial Evaluating Paltusotine in Carcinoid Syndrome" [X Link](https://x.com/doepke_michel/status/1991763374259224615) 2025-11-21T06:59Z 5921 followers, 1288 engagements "$ABVX $RVMD $PTGX trading like a buyout announcement is imminent. Incredible strength" [X Link](https://x.com/doepke_michel/status/1993630538427744637) 2025-11-26T10:38Z 5922 followers, 7557 engagements "$KYMR data in December. Barclays comment below. $NKTR $REGN $SNY $CRVS" [X Link](https://x.com/doepke_michel/status/1995385721541235196) 2025-12-01T06:53Z 5922 followers, 4784 engagements "$CRVS additional data in January Barclays comment below. $NKTR $KYMR $SNY $REGN" [X Link](https://x.com/doepke_michel/status/1995385836947509424) 2025-12-01T06:53Z 5922 followers, 7912 engagements "$CRNX next step 👍" [X Link](https://x.com/doepke_michel/status/1996205752441274743) 2025-12-03T13:11Z 5922 followers, 2264 engagements "$CRNX break. Next target $60" [X Link](https://x.com/doepke_michel/status/1996238654465880385) 2025-12-03T15:22Z 5922 followers, 1966 engagements "Baker Bros are not always right but I consider them to be among the top investors in the biotech scene. Many very successful stocks and M&A candidates with high weighting. 👇 $MDGL $INSM $RYTM $RVMD $CELC $GRAL $ABVX $ARWR" [X Link](https://x.com/doepke_michel/status/1996514558140420440) 2025-12-04T09:38Z 5922 followers, 7109 engagements "IDE034 a Bispecific #ADC Licensed by Biocytogen to $IDYA Receives FDA IND Clearance" [X Link](https://x.com/doepke_michel/status/1996839438018863344) 2025-12-05T07:09Z 5921 followers, 1173 engagements "$VKTX interesting price action yesterday. New FDA guidelines could make an additional phase X for VK2735 obsolete. The stock must break through the $XX area. Then there is plenty of room for more gains" [X Link](https://x.com/doepke_michel/status/1996920762603565293) 2025-12-05T12:33Z 5922 followers, 8703 engagements "$CLDX 52-week high yesterday. The bulls are finally waking up. 2026 will be an extremely important year for Celldex. Small position" [X Link](https://x.com/doepke_michel/status/1996922027513729225) 2025-12-05T12:38Z 5922 followers, XXX engagements "$BPMC a $SNY Company Highlights Long-Term Clinical Benefit of AYVAKIT (avapritinib) Across Indolent and Advanced Systemic Mastocytosis at 2025 ASH Annual Meeting. $COGT" [X Link](https://x.com/doepke_michel/status/1996929129669624106) 2025-12-05T13:06Z 5922 followers, 4235 engagements "The "robots are on the move" see $IRBT. I'm wondering why $BB hasn't jumped yet. But it could still happen. Current share price: $XXXX #QNX #Robotics @Reddit" [X Link](https://x.com/doepke_michel/status/1996938970396348619) 2025-12-05T13:45Z 5922 followers, 1848 engagements "$GMAB Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)" [X Link](https://x.com/doepke_michel/status/1997364848733106487) 2025-12-06T17:57Z 5922 followers, 2306 engagements "$COGT Presents Full SUMMIT Results ofBezuclastinibinPatientswithNonAdvancedSystemic Mastocytosis (NonAdvSM)at the67thAnnual Meeting of the American Society of Hematology (ASH) $BPMC $SNY" [X Link](https://x.com/doepke_michel/status/1997365499621957874) 2025-12-06T18:00Z 5922 followers, 8353 engagements "$ZLAB Announces Updates to Chinas National Reimbursement Drug List" [X Link](https://x.com/doepke_michel/status/1997606381965434931) 2025-12-07T09:57Z 5922 followers, 1422 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@doepke_michel Michel Doepke
Michel Doepke posts on X about $sny, $crnx, $ptgx, market cap the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.
Engagements: XXXXX #
- X Week XXXXXX -XX%
- X Month XXXXXXX -XX%
- X Months XXXXXXXXX +73%
- X Year XXXXXXXXX +146%
Mentions: XX #
- X Week XXX -XX%
- X Month XXX -XX%
- X Months XXXXX +46%
- X Year XXXXX +153%
Followers: XXXXX #
- X Week XXXXX +0.82%
- X Month XXXXX +3.30%
- X Months XXXXX +26%
- X Year XXXXX +51%
CreatorRank: XXXXXXX #
Social Influence
Social category influence stocks XXXXX% cryptocurrencies XXXX% finance XXXX% countries XXXX% travel destinations XXXX%
Social topic influence $sny #2, $crnx #4, $ptgx #7, market cap #235, $bpmc #1, $idya #4, $jnj #21, $11b #10, $abvx #11, $cldx #1
Top accounts mentioned or mentioned by @aggregategains @biohazard3737 @bionavgator @midwit_capital @wallstsai @semodough @amaymd @damiangarde @persimmonti @protagonisttxs @seekingalpha @aktionaer @reddit @meadowcapital @maximizebelief2 @sanityninsanity @mugsley @biotech2k1 @andybradley93 @phoenicianstrat
Top assets mentioned Synthetify (SNY) Crinetics Pharmaceuticals, Inc. (CRNX) Protagonist Therapeutics, Inc (PTGX) Blueprint Medicines Corporation (BPMC) IDEAYA Biosciences, Inc. Common Stock (IDYA) Johnson & Johnson (JNJ) Celldex Therapeutics, Inc (CLDX) Regeneron Pharmaceuticals Inc (REGN) Novartis AG (NVS) Pfizer, Inc. (PFE) Kymera Therapeutics, Inc. Common Stock (KYMR) Cogent Biosciences, Inc. Common Stock (COGT) Insmed, Inc. (INSM) Vertex Protocol (VRTX) GRAIL, Inc. Common Stock (GRAL) Metsera, Inc. Common Stock (MTSR) Ionis Pharmaceuticals, Inc. Common Stock (IONS) Intra-Cellular Therapies Inc. (ITCI) Revolution Medicines, Inc. Common Stock (RVMD) Travere Therapeutics, Inc. Common Stock (TVTX) Eli Lilly and Company (LLY) Exact Sciences Corp (EXAS) Illumina, Inc. (ILMN) GSK plc (GSK) United Community Banks, Inc. (UCB) Dawn Protocol (DAWN) One Cash (ONC) Jazz Pharmaceuticals, Inc. (JAZZ) Seagen Inc (SGEN) Array Technologies, Inc. Common Stock (ARRY) Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Biogen Inc (BIIB) Scholar Rock Holding Corporation Common Stock (SRRK) MON Protocol (MON) uniQure N.V. (QURE) AbbVie Inc (ABBV) Halozyme Therapeutics, Inc. (HALO) Merck & Co., Inc. (MRK) Praxis Precision Medicines, Inc. Common Stock (PRAX) Natera, Inc. Common Stock (NTRA) Agios Pharmaceuticals, Inc. (AGIO) CRISPR Therapeutics AG (CRSP) Lantheus Holdings, Inc (LNTH) Summit Therapeutics Inc. Common Stock (SMMT) Cytokinetics Inc. (CYTK) Edgewise Therapeutics, Inc. Common Stock (EWTX)
Top Social Posts
Top posts by engagements in the last XX hours
"$REGN $SNY Dupixent (dupilumab) Approved as the First Targeted Medicine in the European Union (EU) in Over a Decade for Chronic Spontaneous Urticaria (CSU). $CLDX"
X Link 2025-11-25T06:46Z 5922 followers, 12.2K engagements
"$SNY $BPMC At first glance Ayvakit's weak sales figures are misleading. "Consolidated from July XX 2025. On a pro-forma basis Q3 2025 sales were $204m an increase of XX% from $128m in Q3 2024.""
X Link 2025-10-24T07:09Z 5922 followers, 7260 engagements
"#Otsuka Receives FDA Accelerated Approval for VOYXACT (sibeprenlimab-szsi) for the Reduction of Proteinuria in Adults with Primary Immunoglobulin A Nephropathy (IgAN) at Risk for Disease Progression. $VRTX $NVS $TVTX"
X Link 2025-11-26T12:03Z 5922 followers, 1404 engagements
"Exclusive: I met Jennifer Ruddock CBO of $NKTR at BIO Europe in Vienna. Read the interview (Part 1) 👇 $LLY"
X Link 2025-11-30T09:16Z 5922 followers, 9267 engagements
"$CLDX strength up X% after $JSPR asthma data"
X Link 2025-12-02T17:09Z 5922 followers, 2174 engagements
"$PCSC Freenome and Perceptive Capital Solutions Corp Announce Business Combination Agreement to Create a Publicly Listed Company Transforming Blood-Based Multi-Cancer Detection through an AI/ML-Enabled Multiomics Platform. $GRAL $ILMN $EXAS"
X Link 2025-12-05T13:53Z 5922 followers, 1908 engagements
"$GSK GSK terminates collaboration agreement with $IDYA"
X Link 2025-12-06T06:56Z 5922 followers, 8346 engagements
"$PTGX early stage program but PN-881 could have gamechanger potential. It's incredible how strongly $UCB is growing with Bimzelx. A multi-billion dollar opportunity - and $JNJ may be aware of this potential. Maybe we get a PR tomorrow - $JNJ to report Q3 results on Tuesday. $NVS"
X Link 2025-10-12T18:25Z 5920 followers, 7071 engagements
"$DAWN to Acquire $MRSN - $XX per share + CVR"
X Link 2025-11-13T12:59Z 5920 followers, 1167 engagements
"$ONC Positive Phase X Results Support ZIIHERA as HER2-Targeted Therapy-of-Choice and Combination with TEVIMBRA and Chemotherapy as New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma $JAZZ $ZYME"
X Link 2025-11-17T11:03Z 5918 followers, 3290 engagements
"$SGEN ($43B) $ARNA ($7B) $GBT ($5B) $ARRY ($11B) $MTSR ($8B upfront) $TRIL ($2B) $MDVN ($14B) $BHVN ($12B) = $102B. $PFE market cap: $144B"
X Link 2025-11-18T15:25Z 5920 followers, 131.1K engagements
"Like $PALI into 2026. The stock could get a boost if $ABVX is actually acquired. Interesting: Sharon Skare the new Vice President Global Head of Clinical Operations previously worked at Abivax. She knows how to run larger trials in IBD. Previous jobs at $PFE and $ARNA"
X Link 2025-11-21T13:27Z 5920 followers, 19.7K engagements
"#Eisai Submits New Drug Application for Subcutaneous Formulation of Leqembi for the Treatment of Early Alzheimers Disease in Japan. $BIIB $BIOA.ST"
X Link 2025-11-28T07:08Z 5910 followers, 1846 engagements
"$SRRK strength"
X Link 2025-12-03T16:11Z 5921 followers, 1080 engagements
"Influential study on #glyphosate safety retracted XX years after publication - "several critical issues that are considered to undermine the academic integrity of this article and its conclusions." $MON $BAYN #Bayer #Glyphosat"
X Link 2025-12-04T07:47Z 5906 followers, XXX engagements
"$QURE Provides Regulatory Update on AMT-130 for Huntingtons Disease"
X Link 2025-12-04T12:10Z 5921 followers, 3908 engagements
"$PLRX Announces Interim Data from PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors"
X Link 2025-12-04T12:40Z 5910 followers, 1165 engagements
"What else can $ABBV say Rinvoq and Skyrizi are THE growth drivers in the portfolio following the Humira patent cliff. Competition is not welcome here - I can imagine that AbbVie will purchase/license further assets in this area and in the field of obesity. $ABVX $GUBRA"
X Link 2025-12-04T14:48Z 5920 followers, 2821 engagements
"$HALO Wins Preliminary Injunction Against Merck's Keytruda SC in Germany. $MRK"
X Link 2025-12-04T18:33Z 5920 followers, 2369 engagements
"$PRAX Announces Positive Pre-NDA Meeting with FDA for Ulixacaltamide in Essential Tremor"
X Link 2025-12-04T21:04Z 5921 followers, 2041 engagements
"$NTRA Acquires #Foresight Diagnostics - all-stock transaction consisting of a $XXX million upfront with an additional $XXX million in earnouts tied to the achievement of revenue- and reimbursement-based milestones"
X Link 2025-12-05T12:08Z 5921 followers, 1656 engagements
"$AGIO Announces Topline Results from RISE UP Phase X Trial of Mitapivat in Sickle Cell Disease. $CRSP $VRTX"
X Link 2025-11-19T12:03Z 5921 followers, 3200 engagements
"$KYMR Announces First Patient Dosed in BROADEN2 Phase 2b Atopic Dermatitis Clinical Trial of KT-621 a First-in-Class Oral STAT6 Degrader"
X Link 2025-11-25T12:06Z 5922 followers, 2975 engagements
"$PTGX strength into the weekend. Deal close $JNJ $TAK"
X Link 2025-12-05T20:00Z 5922 followers, 2828 engagements
"$TLX Reports US$206M Revenue FY 2025 Revenue Guidance raised. $LNTH"
X Link 2025-10-14T06:17Z 5923 followers, 1448 engagements
"$SMMT Akeso's Ivonescimab Secures Fourth Breakthrough Therapy Designation in China for First-Line Treatment of Triple-Negative Breast Cancer"
X Link 2025-11-03T06:21Z 5922 followers, 1970 engagements
"$VTYX Provides Clinical and Corporate Updates"
X Link 2025-12-02T12:03Z 5921 followers, 1510 engagements
"$IONS receives U.S. FDA Breakthrough Therapy designation for zilganersen for Alexander disease (AxD)"
X Link 2025-12-02T12:05Z 5921 followers, 1030 engagements
"nHCM landscape (source: Barclays). $CYTK $LXRX $EWTX $TNYA $LXEO"
X Link 2025-10-10T11:25Z 5922 followers, 3309 engagements
"$IDYA 52-week high"
X Link 2025-10-28T13:43Z 5922 followers, 4455 engagements
"$IDYA despite 52-week high just $2.9B market cap. $992M cash at the end of June + $210M upfront payment from Servier. Financed over several years. Multiple shots on goal - I wouldn't be surprised if $IDYA trades above $XXX in the long term"
X Link 2025-10-29T10:25Z 5922 followers, 2459 engagements
"$CRNX Q3 results next Thursday. I like the pipeline potential"
X Link 2025-11-01T13:28Z 5922 followers, 2406 engagements
"$KRYS halted - Buyout"
X Link 2025-11-03T11:56Z 5922 followers, 9363 engagements
"$CRNX pipeline. $1.1B Cash Balance Funds Current Operating Plan into 2029. Market cap: $4B. The focus is now on the commercial roll-out of Palsonify. $CAMX"
X Link 2025-11-07T10:16Z 5922 followers, 8977 engagements
"$COGT Reports Positive Results from Bezuclastinib PEAK Phase X Trial in Gastrointestinal Stromal Tumors (GIST). $BPMC $SNY $DCPH"
X Link 2025-11-10T12:01Z 5921 followers, 17.3K engagements
"$JNJ $ITCI Caplyta estimates: 2025e: $756M 2026e: $1.30B 2027e: $1.75B 2028e: $2.21B Icotrokinra: 2026e: $109M 2027e: $366M 2028e: $974M. Sales could be higher if $JNJ acquires $PTGX"
X Link 2025-11-11T10:57Z 5921 followers, 1197 engagements
"$RLMD should receive more attention here. Small position. $ENGN $CGON"
X Link 2025-11-11T14:58Z 5921 followers, 7666 engagements
"$AXSM new ATH - interesting potential buyout target. $BPMC $ITCI $VRNA and $SWTX gone (see list below)"
X Link 2025-11-12T15:32Z 5921 followers, 3884 engagements
"Next bidding war M&A in the biotech space is heating up $AVDL Board of Directors Determines Proposal From #Lundbeck Reasonably Expected to Result in a Company Superior Proposal. $ALKS"
X Link 2025-11-14T10:53Z 5921 followers, 8217 engagements
"$IONS DAWNZERA (donidalorsen) receives positive opinion from CHMP recommended for approval in EU for hereditary angioedema (HAE)"
X Link 2025-11-14T12:02Z 5921 followers, XXX engagements
"$CRNX looking good"
X Link 2025-11-17T17:03Z 5921 followers, 1315 engagements
"$INSM European Commission Approves BRINSUPRI (brensocatib) as the First and Only Treatment Approved for Non-Cystic Fibrosis Bronchiectasis in the European Union"
X Link 2025-11-19T06:40Z 5921 followers, 1838 engagements
"$RNA Announces U.S. Managed Access Program (MAP) for Investigational Therapy del-zota in DMD44. $NVS $SRPT"
X Link 2025-11-19T14:18Z 5921 followers, 2651 engagements
"What would $PTGX be worth if Icotrokinra and Rusfertide weren't partnered In my opinion $PTGX could be in the range of $INSM in terms of market cap in some years. Large markets ingenious technology (oral). What pharma wants - easily available"
X Link 2025-11-20T14:01Z 5922 followers, 8452 engagements
"$CRNX Announces First Patient Randomized in Pivotal Phase X CAREFNDR Trial Evaluating Paltusotine in Carcinoid Syndrome"
X Link 2025-11-21T06:59Z 5921 followers, 1288 engagements
"$ABVX $RVMD $PTGX trading like a buyout announcement is imminent. Incredible strength"
X Link 2025-11-26T10:38Z 5922 followers, 7557 engagements
"$KYMR data in December. Barclays comment below. $NKTR $REGN $SNY $CRVS"
X Link 2025-12-01T06:53Z 5922 followers, 4784 engagements
"$CRVS additional data in January Barclays comment below. $NKTR $KYMR $SNY $REGN"
X Link 2025-12-01T06:53Z 5922 followers, 7912 engagements
"$CRNX next step 👍"
X Link 2025-12-03T13:11Z 5922 followers, 2264 engagements
"$CRNX break. Next target $60"
X Link 2025-12-03T15:22Z 5922 followers, 1966 engagements
"Baker Bros are not always right but I consider them to be among the top investors in the biotech scene. Many very successful stocks and M&A candidates with high weighting. 👇 $MDGL $INSM $RYTM $RVMD $CELC $GRAL $ABVX $ARWR"
X Link 2025-12-04T09:38Z 5922 followers, 7109 engagements
"IDE034 a Bispecific #ADC Licensed by Biocytogen to $IDYA Receives FDA IND Clearance"
X Link 2025-12-05T07:09Z 5921 followers, 1173 engagements
"$VKTX interesting price action yesterday. New FDA guidelines could make an additional phase X for VK2735 obsolete. The stock must break through the $XX area. Then there is plenty of room for more gains"
X Link 2025-12-05T12:33Z 5922 followers, 8703 engagements
"$CLDX 52-week high yesterday. The bulls are finally waking up. 2026 will be an extremely important year for Celldex. Small position"
X Link 2025-12-05T12:38Z 5922 followers, XXX engagements
"$BPMC a $SNY Company Highlights Long-Term Clinical Benefit of AYVAKIT (avapritinib) Across Indolent and Advanced Systemic Mastocytosis at 2025 ASH Annual Meeting. $COGT"
X Link 2025-12-05T13:06Z 5922 followers, 4235 engagements
"The "robots are on the move" see $IRBT. I'm wondering why $BB hasn't jumped yet. But it could still happen. Current share price: $XXXX #QNX #Robotics @Reddit"
X Link 2025-12-05T13:45Z 5922 followers, 1848 engagements
"$GMAB Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)"
X Link 2025-12-06T17:57Z 5922 followers, 2306 engagements
"$COGT Presents Full SUMMIT Results ofBezuclastinibinPatientswithNonAdvancedSystemic Mastocytosis (NonAdvSM)at the67thAnnual Meeting of the American Society of Hematology (ASH) $BPMC $SNY"
X Link 2025-12-06T18:00Z 5922 followers, 8353 engagements
"$ZLAB Announces Updates to Chinas National Reimbursement Drug List"
X Link 2025-12-07T09:57Z 5922 followers, 1422 engagements